Literature DB >> 11920487

Familial and second gastric carcinomas: a nationwide epidemiologic study from Sweden.

Kari Hemminki1, Yongwen Jiang.   

Abstract

BACKGROUND: Familial risks in gastric carcinoma have been assessed mainly through case-control studies based on reported but not medically verified carcinomas in family members. Reliable data on familial risks are needed for prevention and clinical decisions.
METHODS: The authors used the nationwide Swedish Family-Cancer Database on 10.2 million individuals and more than 34,000 gastric carcinomas to calculate standardized incidence ratios (SIRs) and 95% confidence intervals (CIs) for gastric carcinoma in offspring, from birth to 66 years old, by carcinomas in family members. In addition, SIRs for second gastric carcinomas were analyzed.
RESULTS: Standardized incidence ratios for gastric carcinoma were 1.31 (95% CI, 0.97-1.70) and 1.47 (95% CI, 1.08-1.92) when a parent presented with gastric carcinoma or gastric adenocarcinoma, respectively. The risk was 1.59 (95% CI, 1.10-2.16) in offspring whose diagnosis was at ages older than 50 years. Offspring risk from parental corpus carcinoma was of borderline significance whereas that from cardia carcinoma was below unity. The sibling risk for gastric carcinoma was 3.16 (95% CI, 1.35-5.72) and 5.75 (95% CI, 2.07-11.26) when diagnosed before age 50. The population attributable proportion of familial gastric carcinoma was 0.45%. Risks for second gastric carcinomas were increased in men and women after esophageal and skin carcinomas, and after non-Hodgkin lymphoma.
CONCLUSIONS: The data suggest that environmental factors, perhaps Helicobacter pylori infections are the main reason for familial clustering of gastric carcinoma. The population attributable proportion of familial gastric carcinoma is much lower than that cited in the literature. The patterns of multiple carcinomas suggest that immunologic factors modulate susceptibility to gastric carcinoma. Copyright 2002 American Cancer Society. DOI 10.1002/cncr.10322

Entities:  

Mesh:

Year:  2002        PMID: 11920487

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  8 in total

1.  E-cadherin gene C-160A promoter polymorphism and risk of non-cardia gastric cancer in a Chinese population.

Authors:  Yan Lu; Yao-Chu Xu; Jing Shen; Rong-Bin Yu; Ju-Yin Niu; Jian-Tao Guo; Xu Hu; Hong-Bing Shen
Journal:  World J Gastroenterol       Date:  2005-01-07       Impact factor: 5.742

Review 2.  Clinical genetic counselling for familial cancers requires reliable data on familial cancer risks and general action plans.

Authors:  K Hemminki; C Eng
Journal:  J Med Genet       Date:  2004-11       Impact factor: 6.318

3.  Comparison of patients by family history with gastric and non-gastric cancer.

Authors:  Xue-Fu Zhou; Yu-Long He; Wu Song; Jian-Jun Peng; Chang-Hua Zhang; Wen Li; Hui Wu
Journal:  World J Gastroenterol       Date:  2009-06-07       Impact factor: 5.742

4.  Familial liver and gall bladder cancer: a nationwide epidemiological study from Sweden.

Authors:  K Hemminki; X Li
Journal:  Gut       Date:  2003-04       Impact factor: 23.059

5.  Familial risk of urological cancers: data for clinical counseling.

Authors:  Kari Hemminki; Xinjun Li; Kamila Czene
Journal:  World J Urol       Date:  2003-11-13       Impact factor: 4.226

6.  VEGF and metalloproteinase 2 (MMP 2) expression in gastric cancer tissue.

Authors:  Robert Partyka; Maciej Gonciarz; Przemysław Jałowiecki; Danuta Kokocińska; Tomasz Byrczek
Journal:  Med Sci Monit       Date:  2012-04

7.  Familial risk for gastric carcinoma: an updated study from Sweden.

Authors:  K Hemminki; J Sundquist; J Ji
Journal:  Br J Cancer       Date:  2007-04-03       Impact factor: 7.640

8.  Cancer risks among long-standing spouses.

Authors:  K Hemminki; Y Jiang
Journal:  Br J Cancer       Date:  2002-06-05       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.